Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Viral Susceptibility Gene Panel Mayo Clinic Laboratories Mayo Clinic United States | 35 | 30 |
|
TMC6 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 323 | 329 |
|
Invitae Inborn Errors of Immunity and Cytopenias Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 754 | 562 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Primary Immunodeficiency Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 552 | 424 |
|
Primary Immunodeficiency Panel Baylor Genetics United States | 1 | 463 |
|
CGC Genetics Unilabs Portugal | 1 | 385 |
|
Epidermodysplasia verruciformis (sequence analysis of TMC6 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Melanoma and Other Skin Cancers Panel Mendelics Brazil | 1 | 44 |
|
Hereditary Cancer Panel (Complete) Mendelics Brazil | 1 | 264 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
Epidermodysplasia verruciformis, susceptibility to: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 5 | 5 |
|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 472 |
|
CEN4GEN Comprehensive Hereditary Cancer Syndrome: Gene sequencing Panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 143 |
|
Primary Immunodeficiency Panel Blueprint Genetics Finland | 2 | 275 |
|
Defects in innate immunity Panel CeGaT GmbH Germany | 16 | 19 |
|
Epidermodysplasia verruciformis Bioarray Spain | 1 | 1 |
|
Fulgent Genetics United States | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.